Iclazepam
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
7-chloro-1-[2-(cyclopropylmethoxy)ethyl]-5-phenyl-3H-1,4-benzodiazepin-2-one
|
|
Identifiers | |
CAS Number | 57916-70-8 |
PubChem | CID 68777 |
ChemSpider | 62020 |
UNII | FL061Q6NMC |
ChEMBL | CHEMBL2104257 |
Chemical data | |
Formula | C21H21ClN2O2 |
Molar mass | 368.857 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(verify) |
Iclazepam (Clazepam) is a drug which is a benzodiazepine derivative. It has sedative and anxiolytic effects similar to those produced by other benzodiazepine derivatives, and is around the same potency as chlordiazepoxide.
Iclazepam is a derivative of nordazepam substituted with a cyclopropylmethoxyethyl group on the N1 nitrogen. Once in the body, iclazepam is quickly metabolised to nordazepam and its N-(2-hydroxyethyl) derivative, which are thought to be mainly responsible for its effects.[1]
See also[edit]
References[edit]
- ^ Giudicelli JF, Berdeaux A, Idrissi N, Richer C. Clazepam: pharmacokinetics and effects on performance. British Journal of Clinical Pharmacology. 1978 Jan;5(1):65-9.
This sedative-related article is a stub. You can help Wikipedia by expanding it. |